On April 10, Behrman Capital announced that it entered into an agreement to acquire Vista Apex.
Vista Apex manufactures a variety of consumable dental products for preventative oral hygiene, endodontics and restorative dentistry, including RE-GEN™ Bioactive Bulk Fill Composite, a popular bulk fill, dual-cure methacrylate-based material formulated to allow clinicians to fill all classes of restorations without shrinkage. The company was founded in 1997.
Behrman Capital, a private equity firm, has raised more than $3 billion since its formation in 1991. Healthcare services is one of the firm’s three industry focuses. It is based in New York City.
This transaction is poised to bolster Vista Apex’s growth trajectory by expanding its reach. The press release says that Vista Apex’s management team, led by Chief Executive Officer Scott Lamerand, will continue to lead the company under Behrman’s ownership. Financial terms of the transaction were not disclosed.
According to data captured in the LevinPro HC database, this acquisition marks the 24th Medical Devices transaction of 2024. Between January 1, 2023, and April 10, 2023, 33 Medical Devices deals were reported.
